FDA Inspection
Anjan Drug Private LimitedAnjan Drug Private Limited – FDA Inspection, Aug 16, 2019
Record Details
This FDA Inspection record concerns Anjan Drug Private Limited, with an inspection on August 16, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · c8f9386c-6f7e-48e5-bf56-4ee7128b399f
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1101857
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Anjan Drug Private Limited
5| Date | Classification | Office | Project area |
|---|---|---|---|
| July 11, 2025 | Not classified | Office of Inspections and Investigations | |
| January 31, 2020 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 19, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| January 22, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 11, 2013 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Anjan Drug Private Limited
- FDA Inspection 1277816 - 2025-07-11
- FDA Inspection 1119748 - 2020-01-31
- FDA Inspection 1059806 - 2018-07-19
- FDA Inspection 957358 - 2016-01-22
- FDA Inspection 836031 - 2013-04-11
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.